☆ 4.6 Article

Optical coherence tomography-based misdiagnosis and morphological distinction in pachychoroid neovasculopathy vs. polypoidal choroidal vasculopathy

EYE (2023)

Related references

Note: Only part of the references are listed.

Article Ophthalmology

One-year efficacy of rescue photodynamic therapy for patients with typical age-related macular degeneration, polypoidal choroidal vasculopathy, and pachychoroid neovasculopathy refractory to anti-vascular endothelial growth factor therapy

Iori Wada et al.

Summary: This study evaluated the one-year outcomes of photodynamic therapy (PDT) as a rescue treatment for age-related macular degeneration (AMD) refractory to anti-vascular endothelial growth factor (VEGF) therapy. The study found that PDT could effectively maintain visual acuity and control retinal fluid for up to 12 months in these patients.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2022)

Add to Collection

Article Ophthalmology

Progression of Pachychoroid Neovasculopathy into Aneurysmal Type 1 Choroidal Neovascularization or Polypoidal Choroidal Vasculopathy

Jakob Siedlecki et al.

Summary: This study retrospectively observed the progression of pachychoroid neovasculopathy (PNV) into pachychoroid aneurysmal type 1 choroidal neovascularization (PAT1)/polypoidal choroidal vasculopathy (PCV). It found that younger age at diagnosis and sustained choroidal thickening despite anti-VEGF therapy might be risk factors for PNV progressing into PAT1/PCV.

OPHTHALMOLOGY RETINA (2022)

Add to Collection

Article Ophthalmology

Polypoidal Choroidal Vasculopathy Consensus Nomenclature and Non-Indocyanine Green Angiograph Diagnostic Criteria from the Asia-Pacific Ocular Imaging Society PCV Workgroup

Chui M. Cheung et al.

Summary: A panel of retina specialists developed updated terminology and diagnostic criteria for distinguishing PCV from nAMD based on OCT and color fundus photography findings, achieving high accuracy without the need for ICGA.

OPHTHALMOLOGY (2021)

Add to Collection

Article Ophthalmology

The spectrum of polypoidal choroidal vasculopathy in Caucasians: clinical characteristics and proposal of a classification

Elon H. C. van Dijk et al.

Summary: This study investigated the clinical characteristics and outcome of polypoidal choroidal vasculopathy (PCV) in Caucasian patients, highlighting the association between PCV and different types of choroidal neovascularization in this population. The results showed that most patients with PCV in Caucasians had a thin choroid, and moderate anatomical recovery was observed after treatment for the entire patient group.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2021)

Add to Collection

Article Ophthalmology

One-year comparison of anti-vascular endothelial growth factor and half-dose photodynamic therapies for pachychoroid neovasculopathy

Taiichi Hikichi et al.

Summary: Both anti-VEGF therapy and half-dose PDT showed similar effectiveness in resolving SRF and improving visual acuity in PNV patients over a 1-year period, with no significant differences between the two treatments.

EYE (2021)

Add to Collection

Article Multidisciplinary Sciences

Photodynamic therapy combined with anti-vascular endothelial growth factor therapy for pachychoroid neovasculopathy

Akiko Miki et al.

Summary: This study suggests that a combination of photodynamic therapy (PDT) and anti-vascular endothelial growth factor (VEGF) therapy can significantly improve visual acuity and reduce choroidal and retinal thickness in patients with pachychoroid neovasculopathy (PNV) in the short term, with effects maintained for up to 12 months.

PLOS ONE (2021)

Add to Collection

Article Medicine, General & Internal

Two-Thirds Dose Photodynamic Therapy for Pachychoroid Neovasculopathy

Koji Tanaka et al.

Summary: This study found that reduced dose photodynamic therapy (PDT) for Pachychoroid neovasculopathy (PNV) without polyps (2/3PDT) may be effective in improving visual acuity, decreasing central retinal thickness, and reducing foveal choroidal thickness. Additional intravitreal anti-VEGF agent injections were required in a small percentage of patients, while the majority did not need further treatment during the one-year follow-up period.

JOURNAL OF CLINICAL MEDICINE (2021)

Add to Collection

Article Multidisciplinary Sciences

Long-term outcome of intravitreal anti-vascular endothelial growth factor treatment for pachychoroid neovasculopathy

Jihyun Yoon et al.

Summary: The study found that there was no significant difference in visual acuity improvement among patients with pachychoroid neovasculopathy (PNV), polypoidal choroidal vasculopathy/aneurysmal type 1 neovascularization (PCV/AT1), and typical neovascular age-related macular degeneration (nAMD) after 36 months of anti-vascular endothelial growth factor (VEGF) treatment. However, the PNV group received significantly fewer anti-VEGF injections and had a lower incidence of macular atrophy compared to the typical nAMD group.

SCIENTIFIC REPORTS (2021)

Add to Collection

Article Ophthalmology

Response of neovascular central serous chorioretinopathy to an extended upload of anti-VEGF agents

Benedikt Schworm et al.

GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2020)

Add to Collection

Article Ophthalmology

Comparison of Ranibizumab With or Without Verteporfin Photodynamic Therapy for Polypoidal Choroidal Vasculopathy The EVEREST II Randomized Clinical Trial

Tock H. Lim et al.

JAMA OPHTHALMOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

Characteristics of pachychoroid neovasculopathy

Miho Tagawa et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Review Ophthalmology

Pachychoroid disease

Chui Ming Gemmy Cheung et al.

EYE (2019)

Add to Collection

Article Ophthalmology

Sensitivity and Specificity of Potential Diagnostic Features Detected Using Fundus Photography, Optical Coherence Tomography, and Fluorescein Angiography for Polypoidal Choroidal Vasculopathy

Voraporn Chaikitmongkol et al.

JAMA OPHTHALMOLOGY (2019)

Add to Collection

Article Multidisciplinary Sciences

Choriocapillaris Flow Impairments in Association with Pachyvessel in Early Stages of Pachychoroid

Jiwon Baek et al.

SCIENTIFIC REPORTS (2019)

Add to Collection

Article Multidisciplinary Sciences

Dynamic changes in choroidal conditions during anti-vascular endothelial growth factor therapy in polypoidal choroidal vasculopathy

Norihiro Nagai et al.

SCIENTIFIC REPORTS (2019)

Add to Collection

Article Ophthalmology

Clinicopathologic Correlation of Aneurysmal Type 1 Neovascularization in Age-Related Macular Degeneration

Miaoling Li et al.

OPHTHALMOLOGY RETINA (2019)

Add to Collection

Review Ophthalmology

Polypoidal Choroidal Vasculopathy Definition, Pathogenesis, Diagnosis, and Management

Chui Ming Gemmy Cheung et al.

OPHTHALMOLOGY (2018)

Add to Collection

Review Ophthalmology

Understanding aneurysmal type 1 neovascularization (polypoidal choroidal vasculopathy): a lesson in the taxonomy of expanded spectra' - a review

Kunal K. Dansingani et al.

CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY (2018)

Add to Collection

Article Ophthalmology

Double-layer sign on spectral domain optical coherence tomography in pachychoroid spectrum disease

Jay Sheth et al.

INDIAN JOURNAL OF OPHTHALMOLOGY (2018)

Add to Collection

Article Ophthalmology

Using Electronic Health Records to Build an Ophthalmologic Data Warehouse and Visualize Patients' Data

Karsten U. Kortuem et al.

AMERICAN JOURNAL OF OPHTHALMOLOGY (2017)

Add to Collection

Letter Ophthalmology

Optical Coherence Tomographic Angiography of Choroidal Neovascularization Associated With Central Serous Chorioretinopathy

ScottM. McClintic et al.

JAMA OPHTHALMOLOGY (2015)

Add to Collection

Article Ophthalmology

Visual outcomes of vitrectomy for polypoidal choroidal vasculopathy-related breakthrough vitreous haemorrhage

H-C Lin et al.

EYE (2014)

Add to Collection

Article Ophthalmology

PACHYCHOROID PIGMENT EPITHELIOPATHY

David J. Warrow et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2013)

Add to Collection

Article Ophthalmology

TYPE 1 (SUB-RETINAL PIGMENT EPITHELIAL) NEOVASCULARIZATION IN CENTRAL SEROUS CHORIORETINOPATHY MASQUERADING AS NEOVASCULAR AGE-RELATED MACULAR DEGENERATION

Adrian T. Fung et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2012)

Add to Collection

Article Ophthalmology

EVEREST STUDY Efficacy and Safety of Verteporfin Photodynamic Therapy in Combination with Ranibizumab or Alone Versus Ranibizumab Monotherapy in Patients with Symptomatic Macular Polypoidal Choroidal Vasculopathy

Adrian Koh et al.

RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2012)

Add to Collection

© Peeref 2019-2024. All rights reserved.